Pathophysiology of bladder dysfunction in Parkinson's disease

Neurobiology of Disease

Volumn 46, Issue 3, 2012, Pages 565-571

  Sakakibara, Ryuji ^a   Tateno, Fuyuki ^a   Kishi, Masahiko ^a   Tsuyuzaki, Yohei ^a   Uchiyama, Tomoyuki ^b   Yamamoto, Tatsuya ^b  

^a TOHO UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

Bladder dysfunction; Dopamine D1 receptors; Parkinson's disease

Indexed keywords

ANTIPARKINSON AGENT; BOTULINUM TOXIN; BROMOCRIPTINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DESMOPRESSIN; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; DULOXETINE; LEVODOPA; MILNACIPRAN; OXYBUTYNIN; PERGOLIDE; SEROTONIN AGONIST; TROSPIUM CHLORIDE;

BASAL GANGLION; BLADDER CAPACITY; BLADDER DYSFUNCTION; BLADDER PRESSURE; BLADDER SPHINCTER; BLADDER TRAINING; BLOOD BRAIN BARRIER; BRAIN DEPTH STIMULATION; CLINICAL FEATURE; COGNITIVE DEFECT; CONSTIPATION; DETRUSOR DYSSYNERGIA; DIFFERENTIAL DIAGNOSIS; DRUG CHOICE; DRUG EFFICACY; DRUG PENETRATION; DRUG SAFETY; ELECTROMYOGRAPHY; HUMAN; LOWER URINARY TRACT SYMPTOM; MICTURITION DISORDER; NERVE STIMULATION; NEUROMODULATION; NOCTURIA; NONHUMAN; OVERACTIVE BLADDER; PARKINSON DISEASE; PARKINSONISM; PATHOPHYSIOLOGY; POSTERIOR TIBIAL NERVE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QUALITY OF LIFE; REVIEW; RISK BENEFIT ANALYSIS; SINGLE DRUG DOSE; SUBTHALAMIC NUCLEUS; TRANSURETHRAL RESECTION; TREATMENT CONTRAINDICATION; TREATMENT DURATION; URODYNAMICS; XEROSTOMIA;

BASAL GANGLIA; CHOLINERGIC ANTAGONISTS; DOPAMINE; DOPAMINE AGENTS; ELECTROMYOGRAPHY; HUMANS; MALE; PARKINSON DISEASE; TRANSURETHRAL RESECTION OF PROSTATE; URINARY BLADDER; URINARY BLADDER DISEASES; URINATION; URINATION DISORDERS; URODYNAMICS;

EID: 84860841758     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2011.10.002     Document Type: Review

References (123)

1. Abrams P., Andersson K.E., Buccafusco J.J., Chapple C., de Groat W.C., Fryer A.D., Kay G., Laties A., Nathanson N.M., Pasricha P.J., Wein A.J. Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder. Br. J. Pharmacol. 2006, 148:565-578.
2. Abrams P., Cardozo L., Fall M., Griffiths D., Rosier P., Ulmsten U., van Kerrebroeck P., Victor A., Wein A. Standardisation Sub-committee of the International Continence Society. The standardization of terminology of lower urinary tract function: report from the standardization sub-committee of the International Continence Society. Neurourol. Urodyn. 2002, 21:167-178.
3. Andersen J.T. Disturbances of bladder and urethral function in Parkinson's disease. Int. Urol. Nephrol. 1985, 17:35-41.
4. Andersson K.E. Mechanisms of disease: central nervous system involvement in overactive bladder syndrome. Nat. Clin. Pract. Urol. 2004, 1:103-108.
5. Andrew J., Nathan P.W. Lesions of the anterior frontal lobes and disturbances of micturition and defaecation. Brain 1964, 87:233-262.
6. Andrew J., Nathan P.W. The cerebral control of micturition. Proc. Roy Soc. Med. 1965, 58:553-555.
7. Araki I., Kitahara M., Oida T., Kuno S. Voiding dysfunction and Parkinson's disease: urodynamic abnormalities and urinary symptoms. J. Urol. 2000, 164:1640-1643.
8. Araki I., Kuno S. Assessment of voiding dysfunction in Parkinson's disease by the international prostate symptom score. J. Neurol. Neurosurg. Psychiatry 2000, 68:429-433.
9. Aranda B., Cramer P. Effect of apomorphine and l-dopa on the Parkinsonian bladder. Neurourol. Urodyn. 1993, 12:203-209.
10. Balash Y., Peretz C., Leibovich G., Herman T., Hausdorff J.M., Giladi N. Falls in outpatients with Parkinson's disease: frequency, impact and identifying factors. J. Neurol. 2005, 252:1310-1315.
11. Benson G.S., Raezer D.M., Anderson J.R., Saunders C.D., Corrierie J.N. Effect of levodopa on urinary bladder. Urology 1976, 7:24-28.
12. Berger Y., Blaivas J.G., DeLaRocha E.R., Salinas J.M. Urodynamic findings in Parkinson's disease. J. Urol. 1987, 138:836-838.
13. Betts C.D., Kapoor R., Fowler C.J. Pontine pathology and voiding dysfunction. Br. J. Urol. 1992, 70:100-102.
14. Blok B.F., Holstege G. The central control of micturition and continence: implications for urology. Br. J. Urol. Int. 1999, 83(Suppl 2):1-6.
15. Blok B.F., de Weerd H., Holstege G. The pontine micturition center projects to sacral cord GABA immunoreactive neurons in the cat. Neurosci. Lett. 1997, 233:109-112.
16. Brusa L., Finazzi Agrò E., Petta F., Sciobica F., Torriero S., Lo Gerfo E., Iani C., Stanzione P., Koch G. Effects of inhibitory rTMS on bladder function in Parkinson's disease patients. Mov. Disord. 2009, 24:445-448.
17. Brusa L., Petta F., Pisani A., Miano R., Stanzione P., Moschella V., Galati S., Agro E.F. Central acute D2 stimulation worsens bladder function in patients with mild Parkinson's disease. J. Urol. 2006, 175:202-206.
18. Brusa L., Petta F., Pisani A., Moschella V., Iani C., Stanzione P., Miano R., Finazzi-Agrò E. Acute vs chronic effects of l-dopa on bladder function in patients with mild Parkinson disease. Neurology 2007, 68:1455-1459.
19. Campos-Sousa R.N., Quagliato E., da Silva B.B., De C.R., Ribeiro S.C., de Carvalho D.F. Urinary symptoms in Parkinson's disease: prevalence and associated factors. Arq. Neuropsiquiatr. 2003, 61:359-363.
20. Chandiramani V.A., Palace J., Fowler C.J. How to recognize patients with Parkinsonism who should not have urological surgery. Br. J. Urol. 1997, 80:100-104.
21. Christmas T.J., Chapple C.R., Lees A.J., Kempster P.A., Frankel J.P., Stern G.M. Role of subcutaneous apomorphine in parkinsonian voiding dysfunction. Lancet 1998, 1451-1453. Dec 24/31.
22. Clemens S., Rye D., Hochman S. Restless legs syndrome: revisiting the dopamine hypothesis from the spinal cord perspective. Neurology 2006, 67:125-130.
23. Cooper J.R., Bloom F.E., Roth R.H. The biochemical basis of neuropharmacology. Chapter 9, Dopamine 2003, 225-270. Oxford University press, Oxford. Eighth ed.
24. Dalmose A.L., Bjarkam C.R., Sorensen J.C., Djurhuus J.C., Jorgensen T.M. Effects of high frequency deep brain stimulation on urine storage and voiding function in conscious minipigs. Neurourol. Urodyn. 2004, 23:265-272.
25. Dasgupta R., Kavia R.B., Fowler C.J. Cerebral mechanisms and voiding function. BJU Int. 2007, 99:731-734.
26. de Groat W.C. Integrative control of the lower urinary tract: preclinical perspective. BJP 2006, 147:S25-S40.
27. Donnellan C.A., Fook L., McDonald P., Playfer J.R. Oxybutynin and cognitive dysfunction. BMJ 1997, 315:1363-1364.
28. Dostrovsky J.O., Lozano A.M. Mechanisms of deep brain stimulation. Mov. Disord. 2002, 17(Supple 3):S63-S68.
29. El-Masu M.M., Elmallah A.I., Amal G., Omar A.G., Sharabi F. Dopamine modulates peripheral purinergic neurotransmission through multiple presynaptic receptors: tissue-dependent effects. Pharmacol. Res. 1999, 39:11-19.
30. Finazzi-Agro E., Peppe A., d'Amico A., Petta F., Mazzone P., Stanzione P., Micali F., Caltagirone C. Effects of subthalamic nucleus stimulation on urodynamic findings in patients with Parkinson's disease. J. Urol. 2003, 169:1388-1391.
31. Fitzmaurice H., Fowler C.J., Rickards D., Kirby R.S., Quinn N.P., Marsden C.D., Milroy E.J., Turner-Warwick R.T. Micturition disturbance in Parkinson's disease. Br. J. Urol. 1985, 57:652-656.
32. Fitzmaurice H., Fowler C.J., Rickards D., Kirby R.S., Quinn N.P., Marsden C.D., Milroy E.J., Turner-Warwick R.T. Micturition disturbance in Parkinson's disease. Br. J. Urol. 1985, 57:652-656.
33. Fowler C.J. Integrated control of lower urinary tract: clinical perspective. BJP 2006, 147:S14-S24.
34. Fritsche H.M., Ganzer R., Schlaier J., Wieland W.F., Brawanski A., Lange M. Acute urinary retention in two patients after subthalamic nucleus deep brain stimulation (STN-DBS) for the treatment of advanced Parkinson's disease. Mov. Disord. 2009, 24:1553-1554.
35. Giannantoni A., Rossi A., Mearini E., Del Zingaro M., Porena M., Berardelli A. Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy. J. Urol. 2009, 182:1453-1457.
36. Gibb W.R., Lees A.J., Jenner P., Marsden C.D. The dopamine neurotoxin 1-methyl-4-phenyl- 1,2,3,6-tetrahydropyridine (MPTP) produces histological lesions in the hypothalamus of the common marmoset. Neurosci. Lett. 1986, 65:79-83.
37. Gilman S., Low P.A., Quinn N., Albanese A., Ben-Shlomo Y., Fowler C.J., Kaufmann H., Klockgether T., Lang A.E., Lantos P.L., Litvan I., Mathias C.J., Oliver E., Robertson D., Schatz I., Wenning G.K. Consensus statement on the diagnosis of multiple system atrophy. J. Auton. Nerv. Syst. 1998, 74:189-192.
38. Goldstein D.S., Sewell L., Sharabi Y. Autonomic dysfunction in PD: a window to early detection?. J. Neurol. Sci. 2011, Apr 27. [Epub ahead of print].
39. Gray R., Stern G., Malone-Lee J. Lower urinary tract dysfunction in Parkinson's disease: changes relate to age and not disease. Age Ageing 1995, 24:499-504.
40. Griffiths D., Tadic S.D. Bladder control, urgency, and urge incontinence: evidence from functional brain imaging. Neurourol. Urodyn. 2008, 27:466-474.
41. Hald T., We B. The Urinary Bladder, Neurology and Dynamics 1982, Williams and Wilkins, Baltimore, MD.
42. Halliday G.M., Blumbergs P.C., Cotton R.G., Blessing W.W., Geffen L.B. Loss of brainstem serotonin- and substance P-containing neurons in Parkinson's disease. Brain Res. 1990, 510:104-107.
43. Hashimoto K., Oyama T., Sugiyama T., Park Y.C., Kurita T. Neuronal excitation in the ventral tegmental area modulates the micturition reflex mediated via the dopamine D(1) and D(2) receptors in rats. J. Pharmacol. Sci. 2003, 92:143-148.
44. Hashimoto K., Oyama T., Ukay Y., Kimura K., Sugiyama T., Park Y.C., Kurita T. Selective destruction of dopamine neurones of the ventral tegmental area, but not the substantia nigra, impairs reflex micturition in rats. Neurourol. Urodyn. 1997, 16:470-471.
45. Hattori T., Yasuda K., Kita K., Hirayama K. Voiding dysfunction in Parkinson's disease. Jpn. J. Psychiatry Neurol. 1992, 46:181-186.
46. Herzog J., Weiss P.H., Assmus A., Wefer B., Seif C., Braun P.M., Herzog H., Volkmann J., Deuschl G., Fink G.R. Subthalamic stimulation modulates cortical control of urinary bladder in Parkinson's disease. Brain 2006, 129:3366-3375.
47. Herzog J., Weiss P.H., Assmus A., Wefer B., Seif C., Braun P.M., Pinsker M.O., Herzog H., Volkmann J., Deuschl G., Fink G.R. Improved sensory gating of urinary bladder afferents in Parkinson's disease following subthalamic stimulation. Brain 2008, 131:132-145.
48. Hineno T., Mizobuchi M., Hiratani K., Inami Y., Kakimoto Y. Disappearance of circadian rhythms in Parkinson's disease model induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in dogs. Brain Res. 1992, 580:92-99.
49. Ishizuka O., Igawa Y., Nishizawa O., Andersson K.E. Role of supraspinal tachykinins for volume- and l-dopa-induced bladder activity in normal conscious rats. Neurourol. Urodyn. 2000, 19:101-109.
50. Ishizuka O., Mizusawa H., Nishizawa O. Roles of dopaminergic receptors in bladder and erectile function at the spinal level. Asian J. Androl. 2002, 4:287-290.
51. Ito T., Sakakibara R., Nakazawa K., Uchiyama T., Yamamoto T., Liu Z., Shimizu E., Hattori T. Effects of electrical stimulation of the raphe area on the micturition reflex in cats. Neuroscience 2006, 142:1273-1280.
52. Jain S. Multi-organ autonomic dysfunction in Parkinson disease. Parkinsonism Relat. Disord. 2011, 17:77-83.
53. Kabay S.C., Kabay S., Yucel M., Ozden H. Acute urodynamic effects of percutaneous posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with Parkinson's disease. Neurourol. Urodyn. 2009, 28:62-67.
54. Kavia R.B.C., Dasgupta R., Fowler C.J. Functional imaging and the central control of the bladder. J. Comp. Neurol. 2005, 493:27-32.
55. Kitta T., Kakizaki H., Furuno T., Moriya K., Tanaka H., Shiga T., Tamaki N., Yabe N., Sasaki H., Nonomura K. Brain activation during detrusor overactivity in patients with parkinson's disease: a PET study. J. Urol. 2006, 175:994-998.
56. Kitta T., Matsumoto M., Tanaka H., Mitsui T., Yoshioka M., Nonomura K. GABAergic mechanism mediated via D receptors in the rat periaqueductal gray participates in the micturition reflex: an in vivo microdialysis study. Eur. J. Neurosci. 2008, 27:3216-3225.
57. Kono M., Nakamura Y., Ishiura Y., Komatsu K., Kontani H., Namiki M. Central muscarinic receptor subtypes regulating voiding in rats. J. Urol. 2006, 175:353-357.
58. Kulaksizoglu H., Parman Y. Use of botulinum toxin-A for the treatment of overactive bladder symptoms in patients with Parkinsons's disease. Parkinsonism Relat. Disord. 2010, 16:531-534.
59. Kuno S., Mizuta E., Yamasaki S., Araki I. Effects of pergolide on nocturia in Parkinson's disease: three female cases selected from over 400 patients. Parkinsonism Relat. Disord. 2004, 10:181-187.
60. Lemack G.E., Dewey R.B., Roehrborn C.G., O'Suilleabhain P.E., Zimmern P.E. Questionnaire-based assessment of bladder dysfunction in patients with mild to moderate Parkinson's disease. Urology 2000, 56:250-254.
61. Liu Z., Sakakibara R., Nakazawa K., Uchiyama T., Yamamoto T., Ito T., Hattori T. Micturition-related neuronal firing in the periaqueductal gray area in cats. Neuroscience 2004, 126:1075-1082.
62. Magerkurth C., Schnitzer R., Braune S. Symptoms of autonomic failure in Parkinson's disease: prevalence and impact on daily life. Clin. Auton. Res. 2005, 15:76-82.
63. Matsui H., Nishinaka K., Oda M., Komatsu K., Kubori T., Udaka F. Does cardiac metaiodobenzylguanidine (MIBG) uptake in Parkinson's disease correlate with major autonomic symptoms?. Parkinsonism Relat. Disord. 2006, 12:284-288.
64. Matsumoto G., Hisamitsu T., De Groat W.C. Role of glutamate and NMDA receptors in the descending limb of the spinobulbospinal micturition reflex pathway of the rat. Neurosci. Lett. 1995, 183:58-61.
65. Matsuura S., Downie J.W., Allen G.V. Volume-evoked micturition reflex is mediated by the ventrolateral periaqueductal gray in anesthetized rat. Am. J. Physiol. 1998, 275:R2049-R2055.
66. McGrother C.W., Jagger C., Clarke M., Castleden C.M. Handicaps associated with incontinence: implications for management. J. Epidemiol. Commun. Health 1990, 44:246-248.
67. McKeith I.G., Dickson D.W., Lowe J., Emre M., O'Brien J.T., Feldman H., Cummings J., Duda J.E., Lippa C., Perry E.K., Aarsland D., Arai H., Ballard C.G., Boeve B., Burn D.J., Costa D., Del Ser T., Dubois B., Galasko D., Gauthier S., Goetz C.G., Gomez-Tortosa E., Halliday G., Hansen L.A., Hardy J., Iwatsubo T., Kalaria R.N., Kaufer D., Kenny R.A., Korczyn A., Kosaka K., Lee V.M., Lees A., Litvan I., Londos E., Lopez O.L., Minoshima S., Mizuno Y., Molina J.A., Mukaetova-Ladinska E.B., Pasquier F., Perry R.H., Schulz J.B., Trojanowski J.Q., Yamada M. Consortium on DLB. Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium. Neurology 2005, 65:1863-1872.
68. Murnaghan G.F. Neurogenic disorders of the bladder in Parkinsonism. Br. J. Urol. 1961, 33:403-409.
69. Nour S., Svarer C., Kristensen J.K., Law I. Cerebral activation during micturition in normal men. Brain 2000, 123:781-789.
70. O'Sullivan S.S., Holton J.L., Massey L.A., Williams D.R., Revesz T., Lees A.J. Parkinson's disease with Onuf's nucleus involvement mimicking multiple system atrophy. J. Neurol. Neurosurg. Psychiatry 2008, 79:232-234.
71. Obeso J.A., Olanow C.W., Nutt J.G. Levodopa motor complications in Parkinson's disease. Trend Neurosci. 2000, 23:S2-S7.
72. Palleschi G., Pastore A.L., Stocchi F., Bova G., Inghilleri M., Sigala S., Carbone A. Correlation between the Overactive Bladder questionnaire (OAB-q) and urodynamic data of Parkinson disease patients affected by neurogenic detrusor overactivity during antimuscarinic treatment. Clin. Neuropharmacol. 2006, 29:220-229.
73. Pavlakis A.J., Siroky M.B., Goldstein I., Krane R.J. Neurourologic findings in Parkinson's disease. J. Urol. 1983, 129:80-83.
74. Roth B., Studer U.E., Fowler C.J., Kessler T.M. Benign prostatic obstruction and Parkinson's disease-should transurethral resection of the prostate be avoided?. J. Urol. 2009, 181:2209-2213.
75. Routh J.C., Crimmins C.R., Leibovich B.C., Elliott D.S. Impact of Parkinson's disease on continence after radical prostatectomy. Urology 2006, 68:575-577.
76. Sakakibara R., Fowler C.J. Brain disease (chapter 9). Seminars in Clinical Neurology (by World Federation of Neurology). Neurologic bladder, bowel, and sexual function 2001, 229-243. Elsevier, Boston. C.J. Fowler (Ed.).
77. Sakakibara R., Hattori T., Uchiyama T., Yamanishi T. Urinary function in the elderly with and without leukoaraiosis; in relation to cognitive and gait function. J. Neurol. Neurosurg. Psychiatry 1999, 67:658-660.
78. Sakakibara R., Hattori T., Uchiyama T., Yamanishi T. Videourodynamic and sphincter motor unit potential analyses in Parkinson's disease and multiple system atrophy. J. Neurol. Neurosurg. Psychiatry 2001, 71:600-606.
79. Sakakibara R., Hattori T., Yasuda K., Yamanishi T., Tojo M., Mori M. Micturitional disturbance in Wernicke's encephalopathy. Neurourol. Urodyn. 1997, 16:111-115.
80. Sakakibara R., Hattori T., Yasuda K., Yamanishi T. Micturitional disturbance and pontine tegmental lesion; urodynamic and MRI analyses of the vascular cases. J. Neurol. Sci. 1996, 141:105-110.
81. Sakakibara R., Ito T., Uchiyama T., Asahina M., Liu Z., Yamamoto T., Yamanaka Y., Hattori T. Lower urinary tract function in dementia of Lewy body type (DLB). J. Neurol. Neurosurg. Psychiatry 2005, 76:729-732.
82. Sakakibara R., Ito T., Uchiyama T., Awa Y., Yamaguchi C., Hattori T. Effects of milnacipran and paroxetine on overactive bladder due to neurologic diseases: a urodynamic assessment. Urol. Int. 2008, 81:335-339.
83. Sakakibara R., Mori M., Fukutake T., Kita K. Orthostatic hypotension in a case with multiple sclerosis. Clin. Auton. Res. 1997, 7:163-165.
84. Sakakibara R., Nakazawa K., Shiba K., Nakajima Y., Uchiyama T., Yoshiyama M., Yamanishi T., Hattori T. Firing patterns of micturition-related neurons in the pontine storage centre in cats. Auton. Neurosci. 2002, 99:24-30.
85. Sakakibara R., Nakazawa K., Uchiyama T., Yoshiyama M., Yamanishi T., Hattori T. Micturition-related electrophysiological properties in the substantia nigra pars compacta and the ventral tegmental area in cats. Auton. Neurosci. 2002, 102:30-38.
86. Sakakibara R., Nakazawa K., Uchiyama T., Yoshiyama M., Yamanishi T., Hattori T. Effects of subthalamic nucleus stimulation on the micturation reflex in cats. Neuroscience 2003, 120:871-875.
87. Sakakibara R., Ogata T., Uchiyama T., Kishi M., Ogawa E., Isaka S., Yuasa J., Yamamoto T., Ito T., Yamanishi T., Awa Y., Yamaguchi C., Takahashi O. How to manage overactive bladder in elderly individuals with dementia? A combined use of donepezil, a central AChE inhibitor, and propiverine, a peripheral muscarine receptor antagonist. J. Am. Geriatr. Soc. 2009, 57:1515-1517.
88. Sakakibara R., Shinotoh H., Uchiyama T., Sakuma M., Kashiwado M., Yoshiyama M., Hattori T. Questionnaire-based assessment of pelvic organ dysfunction in Parkinson's disease. Auton. Neurosci. 2001, 92:76-85.
89. 123I]-beta-CIT reveals marked decline of nigrostriatal dopaminergic function in Parkinson's disease with urinary dysfunction. J. Neurol. Sci. 2001, 187:55-59.
90. Sakakibara R., Uchiyama T., Hattori T., Yamanishi T. Urodynamic evaluation in Parkinson's disease before and after levodopa treatment. 9th International Catechecholamine Symposium, Kyoto, Japan 2001.
91. Sakakibara R., Uchiyama T., Yamanishi T., Kishi M. Dementia and lower urinary dysfunction: with a reference to anticholinergic use in elderly population. Int. J. Urol. 2008, 15:778-788.
92. Sakakibara R., Uchiyama T., Yamanishi T., Shirai K., Hattori T. Bladder and bowel dysfunction in Parkinson's disease. J. Neural Transm. 2008, 115:443-460.
93. Sakakibara R., Uchiyama T., Yoshiyama M., Yamanishi T., Hattori T. Preliminary communication: urodynamic assessment of donepezil hydrochloride in patients with Alzheimer's disease. Neurourol. Urodyn. 2005, 24:273-275.
94. Sasaki M. Role of Barrington's nucleus in micturition. J. Comp. Neurol. 2005, 493:21-26.
95. Scheife R., Takeda M. Central nervous system safety of anticholinergic drugs for the treatment of overactive bladder in the elderly. Clin. Ther. 2005, 27:144-153.
96. Seif C., Herzog J., van der H.C., Schrader B., Volkmann J., Deuschl G., Juenemann K.P., Braun P.M. Effect of subthalamic deep brain stimulation on the function of the urinary bladder. Ann. Neurol. 2004, 55:118-120.
97. Seki S., Igawa Y., Kaidoh K., Ishizuka O., Nishizawa O., Andersson K.E. Role of dopamine D1 and D2 receptors in the micturition reflex in conscious rats. Neurourol. Urodyn. 2001, 20:105-113.
98. Smith Y., Bevan M.D., Shink E., Bolam J.P. Microcircuitry of the direct and indirect pathways of the basal ganglia. Neuroscience 1998, 86:353-387.
99. Steers W.D. Pathophysiology of overactive and urge urinary incontinence. Rev. Urol. 2002, 4(Suppl 4):S7-S18.
100. Stocchi F., Carbone A., Inghilleri M., Monge A., Ruggieri S., Berardelli A., Manfredi M. Urodynamic and neurophysiological evaluation in Parkinson's disease and multiple system atrophy. J. Neurol. Neurosurg. Psychiatry 1997, 62:507-511.
101. Suchowersky O., Furtado S., Rohs G. Beneficial effect of intranasal desmopressin for nocturnal polyuria in Parkinson's disease. Mov. Disord. 1995, 10:337-340.
102. Uchiyama T., Sakakibara R., Hattori T., Yamanishi T. Short-term effect of a single levodopa dose on micturition disturbance in Parkinson's disease patients with the wearing-off phenomenon. Mov. Disord. 2003, 18:573-578.
103. Uchiyama T., Sakakibara R., Hattori T. Lower urinary tract dysfunctions of Parkinson's disease model rat (6-hydroxydopamine treated rat) and effects of drugs. Autonom. Nerv. Syst. 2006, 43:302-308. (in Japanese, review with clinical data).
104. Uchiyama T., Sakakibara R., Yamamoto T., Ito T., Yamaguchi C., Awa Y., Yano M., Yanagisawa M., Kobayashi M., Higuchi Y., Ichikawa T., Yamanishi T., Hattori T., Kuwabara S. Comparing bromocriptine effects with levodopa effects on bladder function in Parkinson's disease. Mov. Disord. 2009, 24:2386-2390.
105. Uchiyama T., Sakakibara R., Yoshiyama M., Yamamoto T., Ito T., Liu Z., Yamaguchi C., Awa Y., Yano H.M., Yanagisawa M., Yamanishi T., Hattori T., Kuwabara S. Biphasic effect of apomorphine, an anti-parkinsonian drug, on bladder function in rats. Neuroscience 2009, 162:1333-1338.
106. Vaughan C.P., Juncos J.L., Burgio K.L., Goode P.S., Wolf R.A., Johnson T.M. Behavioral therapy to treat urinary incontinence in Parkinson disease. Neurology 2011, 76:1631-1634.
107. Wein A.J., Rackley R.R. Overactive bladder: a better understanding of pathophysiology, diagnosis and management. J. Urol. 2006, 175:S5-S10.
108. Winge K., Friberg L., Werdelin L., Nielsen K.K., Stimpel H. Relationship between nigrostriatal dopaminergic degeneration, urinary symptoms, and bladder control in Parkinson's disease. Eur. J. Neurol. 2005, 12:842-850.
109. Winge K., Nielsen K.K., Stimpel H., Lokkegaard A., Jensen S.R., Werdelin L. Lower urinary tract symptoms and bladder control in advanced Parkinson's disease: effects of deep brain stimulation in the subthalamic nucleus. Mov. Disord. 2007, 22:220-225.
110. Winge K., Werdelin L.M., Nielsen K.K., Stimpel H. Effects of dopaminergic treatment on bladder function in Parkinson's disease. Neurourol. Urodyn. 2004, 23:689-696.
111. Yaguchi H., Soma H., Miyazaki Y., Tashiro J., Yabe I., Kikuchi S., Sasaki H., Kakizaki H., Moriwaka F., Tashiro K. A case of acute urinary retention caused by periaqueductal grey lesion. J. Neurol. Neurosurg. Psychiatry 2004, 75:1202-1203.
112. Yamamoto M. Pergolide improves neurogenic bladder in patients with Parkinson's disease. Mov. Disord. 1997, 12:328.
113. Yamamoto T., Sakakibara R., Hashimoto K., Nakazawa K., Uchiyama T., Liu Z., Ito T., Hattori T. Striatal dopamine level increases in the urinary storage phase in cats: an in vivo microdialysis study. Neuroscience 2005, 135:299-303.
114. Yamamoto T., Sakakibara R., Nakazawa K., Uchiyama T., Shimizu E., Hattori T., Kuwabara S. Neuronal activities of forebrain structures with respect to bladder contraction in cats. Neurosci. Lett. 2010, 473:42-47.
115. Yamamoto T., Sakakibara R., Nakazawa K., Uchiyama T., Shimizu E., Hattori T. Effects of electrical stimulation of the striatum on bladder activity in cats. Neurourol. Urodyn. 2009, 28:549-554.
116. Yamamoto T., Sakakibara R., Uchiyama T., Liu Z., Ito T., Awa Y., Yamanishi T., Hattori T. Neurological diseases that cause detrusor hyperactivity with impaired contractile function. Neurourol. Urodyn. 2006, 25:356-360.
117. Yokoyama O., Yoshiyama M., Namiki M., de Groat W.C. Changes in dopaminergic and glutamatergic excitatory mechanisms of micturition reflex after middle cerebral artery occlusion in conscious rats. Exp. Neurol. 2002, 173:129-135.
118. Yokoyama O., Yotsuyanagi S., Akino H., Moriyama H., Matsuta Y., Namiki M. RNA synthesis in pons necessary for maintenance of bladder overactivity after cerebral infarction in rat. J. Urol. 2003, 169:1878-1884.
119. Yoshida A., Fujino T., Maruyama S., Ito Y., Taki Y., Yamada S. The forefront for novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: bladder selectivity based on in vivo drug-receptor binding characteristics of antimuscarinic agents for treatment of overactive bladder. J. Pharmacol. Sci. 2010, 112:142-150.
120. Yoshimura N., Kuno S., Chancellor M.B., de Groat W.C., Seki S. Dopaminergic mechanisms underlying bladder hyperactivity in rats with a unilateral 6-hydroxydopamine (6-OHDA) lesion of the nigrostriatal pathway. Br. J. Pharmacol. 2003, 139:1425-1432.
121. Yoshimura N., Mizuta E., Yoshida O., Kuno S. Therapeutic effects of dopamine D1/D2 receptor agonists on detrusor hyperreflexia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine- lesioned parkinsonian cynomolgus monkeys. J. Pharmacol. Exp. Ther. 1998, 286:228-233.
122. Yoshimura N., Sasa M., Yoshida O., Takaori S. Dopamine D-1 receptor mediated inhibition of micturition reflex by central dopamine from the substantia nigra. Neurourol. Urodyn. 1992, 11:535-545.
123. Galloway N.T. Urethral sphincter abnormalities in Parkinsonism. Br. J. Urol. 1983, 55:691-693.